International Clinical Trial: Efficacy and safety of colistimethate sodium in treating carbapenem-resistant Gram-negative bacterial infections: an open-label, single-center, single-arm study in Chinese adults

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114879) titled 'Efficacy and safety of colistimethate sodium in treating carbapenem-resistant Gram-negative bacterial infections: an open-label, single-center, single-arm study in Chinese adults' on Dec. 18, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Tangdu Hospital of the Fourth Military Medical University

Condition: Infections caused by carbapenem-resistant Gram-negative bacteria (CR-GNB)

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2024-03-26

Target Sample Size: Intervention group:36;

Countries of Recruitment: China

To know more, visit https://www.c...